<p><h1>Insights into Preimplantation Genetic Screening Market Size: Analysing Market Share, Trends, and Growth from 2024 to 2031</h1></p><p><strong>Preimplantation Genetic Screening Market Analysis and Latest Trends</strong></p>
<p><p>Preimplantation Genetic Screening (PGS) is a screening method used during in vitro fertilization (IVF) to analyze embryos for chromosomal abnormalities before they are implanted into the mother's uterus. It involves the removal of one or a few cells from an embryo and their subsequent genetic analysis to ensure the selection of healthy embryos for implantation.</p><p>The global Preimplantation Genetic Screening market is expected to witness substantial growth during the forecast period. The market growth can be attributed to several factors such as the increasing prevalence of genetic disorders, advancements in technology, growing awareness among couples about genetic screening, and rising demand for healthy babies. Additionally, the growing trend of delayed pregnancies due to career advancements and lifestyle changes further boosts the demand for PGS.</p><p>Various technological advancements have contributed to the growth of the Preimplantation Genetic Screening market. These include the development of Next-Generation Sequencing (NGS) technology, which allows for more accurate and comprehensive screening of embryos, and the increasing use of single-nucleotide polymorphism (SNP) arrays for genetic analysis.</p><p>Moreover, the market is witnessing several trends that are shaping its growth. One such trend is the increasing adoption of non-invasive prenatal testing (NIPT), which eliminates the need for invasive procedures such as amniocentesis and chorionic villus sampling. Another emerging trend is the use of PGS for selecting embryos with specific genetic traits, such as gender selection or to prevent the transmission of inheritable diseases.</p><p>In conclusion, the Preimplantation Genetic Screening Market is expected to grow at a CAGR of 8.8% during the forecast period. Factors such as increasing prevalence of genetic disorders, technological advancements, and rising awareness among couples about genetic screening are driving market growth. Additionally, the adoption of non-invasive prenatal testing and the use of PGS for selecting embryos with specific genetic traits are some of the latest trends in the market.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp;</strong> <a href="https://www.reliableresearchreports.com/enquiry/request-sample/1838736">https://www.reliableresearchreports.com/enquiry/request-sample/1838736</a></p>
<p>&nbsp;</p>
<p><strong>Preimplantation Genetic Screening Major Market Players</strong></p>
<p><p>The preimplantation genetic screening (PGS) market is highly competitive, with several key players dominating the industry. Some of the prominent players in the market include Illumina, Inc, Thermo Fisher Scientific Inc, Agilent Technologies, Inc, PerkinElmer, Inc, CooperSurgical, Inc, and Beijing Genomics Institute (BGI).</p><p>Illumina, Inc, based in the US, is a leading player in the PGS market. The company offers a comprehensive range of genetic testing solutions, including next-generation sequencing (NGS) platforms and other genomic analysis tools. Illumina's market growth has been driven by its strong focus on research and development, strategic partnerships, and acquisitions in the genomics field. The company has consistently shown steady growth in sales revenue, with a year-on-year increase of around 6% in 2020.</p><p>Thermo Fisher Scientific Inc, also based in the US, is another major player in the PGS market. The company offers a wide range of genetic analysis and sequencing tools to support PGS. Thermo Fisher Scientific has witnessed significant market growth due to its extensive product portfolio and strong global presence. The company's sales revenue has grown steadily, with a year-on-year increase of approximately 22% in 2020.</p><p>Agilent Technologies, Inc, based in the US, provides a range of genetic analysis solutions for PGS, including microarray technology and NGS platforms. Agilent Technologies has shown consistent growth in the PGS market, driven by the increasing demand for genetic testing and personalized medicine. The company's sales revenue witnessed a year-on-year increase of around 11% in 2020.</p><p>PerkinElmer, Inc, headquartered in the US, offers various genetic testing solutions, including microarray and NGS platforms for PGS. The company has witnessed steady growth in sales revenue, with a year-on-year increase of approximately 7% in 2020. PerkinElmer's market growth can be attributed to its focus on technological advancements and collaborations with key industry stakeholders.</p><p>CooperSurgical, Inc, based in the US, is a leading player in the field of reproductive medicine, including PGS. The company offers a comprehensive range of products and services for assisted reproductive technology. CooperSurgical's market growth has been driven by its strong focus on product innovation, research and development, and strategic acquisitions. However, specific sales revenue figures for the company are not readily available.</p><p>Beijing Genomics Institute (BGI), based in China, is a global genomics research institution and a key player in the PGS market. BGI offers a wide range of genetic analysis solutions, including NGS platforms and data analysis tools. The company has witnessed rapid growth in recent years, expanding its global presence and establishing partnerships with various research institutions and healthcare organizations. BGI's market size and specific sales revenue figures are not publicly available.</p><p>Overall, the PGS market is highly competitive, with key players such as Illumina, Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, CooperSurgical, and BGI driving market growth through continuous innovation, strategic collaborations, and global expansion. These companies are expected to continue growing in the future as the demand for genetic testing and personalized medicine increases.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Preimplantation Genetic Screening Manufacturers?</strong></p>
<p><p>The preimplantation genetic screening (PGS) market is experiencing significant growth due to advancements in assisted reproductive technologies and increasing awareness about genetic disorders. The market is driven by factors such as rising infertility rates, growing use of in vitro fertilization, and rising demand for healthy babies. Moreover, the integration of PGS with next-generation sequencing is further propelling market growth. However, high costs associated with PGS procedures and ethical concerns are expected to hinder market growth to some extent. Nevertheless, the increasing adoption of PGS by couples at a high risk of genetic disorders and the development of non-invasive PGS techniques offer potential growth opportunities for the market.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report:</strong> <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1838736">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1838736</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Preimplantation Genetic Screening Market Analysis by types is segmented into:</strong></p>
<p><ul><li>Next Generation Sequencing (NGS)</li><li>Polymerase Chain Reaction (PCR)</li><li>Fluorescent In-situ Hybridization (FISH)</li><li>Comparative Genomic Hybridization (CGH)</li><li>Single Nucleotide Polymorphism (SNP)</li></ul></p>
<p><p>The Preimplantation Genetic Screening (PGS) market offers various types of techniques to analyze embryos for genetic abnormalities before implantation. Next Generation Sequencing (NGS) uses advanced DNA sequencing technology, Polymerase Chain Reaction (PCR) amplifies specific DNA segments, Fluorescent In-situ Hybridization (FISH) identifies genetic abnormalities using fluorescent probes, Comparative Genomic Hybridization (CGH) identifies chromosomal abnormalities, and Single Nucleotide Polymorphism (SNP) analyzes variations in single nucleotides. These techniques help identify genetic disorders and enable professionals to select the healthiest embryos for implantation, improving the success rates of fertility treatments.</p></p>
<p><strong>Purchase this Report:&nbsp;</strong><a href="https://www.reliableresearchreports.com/purchase/1838736">https://www.reliableresearchreports.com/purchase/1838736</a></p>
<p>&nbsp;</p>
<p><strong>The Preimplantation Genetic Screening Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Single Gene Disorders</li><li>X-linked Disorders</li><li>HLA Typing</li><li>Gender Identification</li></ul></p>
<p><p>Preimplantation genetic screening (PGS) is a technique used in assisted reproductive technology to identify and select embryos with specific genetic traits. The application of PGS includes screening for single gene disorders, which allows identification of embryos carrying harmful genetic mutations. X-linked disorders can also be screened, targeting genes located on the X chromosome. PGS can also be used for HLA typing, enabling the selection of embryos that can potentially provide compatible stem cells for future transplantation. Additionally, PGS facilitates gender identification, helping individuals and couples choose the gender of their future child.</p></p>
<p>&nbsp;</p>
<p><strong>In terms of Region, the Preimplantation Genetic Screening Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The preimplantation genetic screening (PGS) market is experiencing substantial growth globally, with prominent regions such as North America (NA), Asia Pacific (APAC), Europe, the United States (USA), and China emerging as key contributors. North America, driven by advanced healthcare infrastructure, increasing adoption of PGS techniques, and availability of technologically advanced equipment, is anticipated to dominate the market. It is estimated to account for a market share of approximately 35-40%. Europe and the United States are also expected to hold significant market shares, with shares ranging from 25-30% and 15-20% respectively. Asia Pacific, primarily driven by rising awareness, improving healthcare facilities, and increasing disposable income, is anticipated to witness considerable growth and account for a market share of around 10-15%. China, due to its large population and increasing healthcare expenditure, is expected to witness substantial growth and secure a market share of approximately 10%.</p></p>
<p><strong>Purchase this Report: </strong><a href="https://www.reliableresearchreports.com/purchase/1838736">https://www.reliableresearchreports.com/purchase/1838736</a></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;</strong><a href="https://www.reliableresearchreports.com/enquiry/request-sample/1838736">https://www.reliableresearchreports.com/enquiry/request-sample/1838736</a></p>
<p><strong></strong></p>
<p><p><a href="https://medium.com/@kcekkboop72786/leafy-green-vegetable-seeds-market-outlook-industry-overview-and-forecast-2024-to-2031-bd615db72e7a">Leafy Green Vegetable Seeds Market</a></p><p><a href="https://github.com/marloy8/Market-Research-Report-List-2/blob/main/industrial-control-systems-security-solutions-market.md">Industrial Control Systems Security Solutions Market</a></p><p><a href="https://medium.com/@kcekkboop72786/active-automotive-safety-systems-market-size-cagr-trends-2024-2030-6552066d8202">Active Automotive Safety Systems Market</a></p><p><a href="https://github.com/aliciawhite5576/Market-Research-Report-List-2/blob/main/exosome-technologies-market.md">Exosome Technologies Market</a></p><p><a href="https://medium.com/@kcekkboop72786/passive-automotive-safety-systems-market-outlook-industry-overview-and-forecast-2024-to-2031-755759784db3">Passive Automotive Safety Systems Market</a></p></p>